Makers Laboratories Limited (BOM:506919)
India
· Delayed Price · Currency is INR 147.55
+5.40 (3.80%)
At close: Mar 10, 2026
Makers Laboratories Revenue
Makers Laboratories had revenue of 356.68M INR in the quarter ending December 31, 2025, with 28.81% growth. This brings the company's revenue in the last twelve months to 1.39B, up 21.01% year-over-year. In the fiscal year ending March 31, 2025, Makers Laboratories had annual revenue of 1.21B with 15.67% growth.
Revenue (ttm)
1.39B
Revenue Growth
+21.01%
P/S Ratio
0.60
Revenue / Employee
10.59M
Employees
131
Market Cap
838.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.21B | 163.62M | 15.67% |
| Mar 31, 2024 | 1.04B | 31.12M | 3.07% |
| Mar 31, 2023 | 1.01B | -268.89M | -20.98% |
| Mar 31, 2022 | 1.28B | 595.25M | 86.72% |
| Mar 31, 2021 | 686.41M | 172.45M | 33.55% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Source Natural Foods and Herbal Supplements | 654.13M |
| Mercury Laboratories | 761.53M |
| Concord Drugs | 512.41M |
| Accretion Pharmaceuticals | 826.43M |
| Amwill Health Care | 386.31M |
| Asston Pharmaceuticals | 244.84M |
| Lactose (India) | 1.45B |
| Bal Pharma | 3.09B |